Project Grant R35GM164182
- Federal Project Grant Award Summary The Salk Institute for Biological Studies received a $943,750 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 5, 2025, with a completion date of July 31, 2030. The award supports fundamental research into peptide-receptor signaling in plant-microbe interactions, specifically examining cellular decision-making mechanisms and...
- Federal Project Grant Award Summary The Salk Institute for Biological Studies received a $1.2 million Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) awarded July 15, 2025, with a completion date of July 14, 2026. The award funds the acquisition and deployment of a Thermo Fisher Scientific Orbitrap IQ-X Tribrid mass spectrometer equipped with an Ultrahigh Performance Liquid Chromatography...
- Federal Grant Award Summary The Salk Institute for Biological Studies received a $150,104 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded February 1, 2026, with completion targeted for October 31, 2028. The research, conducted in La Jolla, California under the mentorship of Dr. Fred Gage, focuses on developing an advanced in vitro method for...
- Federal Grant Award Summary The University of California, Berkeley received a $617,574 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 9, 2026, with a completion date of February 28, 2030. This award supports fundamental research investigating the mechanisms of site-specific non-LTR retrotransposon mobility and transgene insertion in animal genomes. The research focuses on...
- Federal Project Grant Award Summary The Sloan-Kettering Institute for Cancer Research received a $528,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective April 15, 2026, with a completion date of January 31, 2031. The award supports fundamental research investigating histone glycation as a dynamic epigenetic modification mechanism. The research focuses on understanding how...
- Federal Grant Award Summary The University of California, Berkeley received a $152,300 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 1, 2026, through February 28, 2029. The Nogales Lab will conduct fundamental structural and biochemical research to elucidate molecular mechanisms underlying regulator-dependent transcription initiation pathways. Specifically, the research will...
- Federal Project Grant Award Summary The University of California, Irvine received a $380,540 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through June 30, 2030. This award supports investigator-initiated research investigating epigenetic regulation mechanisms in human embryonic stem cell (hESC) lineage specification. The research program will examine...
- Federal Grant Award Summary The University of California, San Diego received a $375,000 Project Grant from the National Science Foundation (NSF) Division of Molecular and Cellular Biosciences under the Biological Sciences program (CFDA 47.074). The four-year award, active from August 1, 2025 through July 31, 2029, supports collaborative research investigating analog information storage in chromatin states—specifically how cells maintain identity information through gene expression regulation...
- Federal Grant Award Summary Saint Louis University received a $385,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2028. The award supports fundamental research to characterize the functions of ATALKBH4, a putative DNA N6-adenine methylation (6MA) demethylase in plants. The research aims to advance understanding of how 6MA and its...
- Federal Grant Award Summary The University of California, San Diego received a Project Grant award of $376,498 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 1, 2025, with a completion date of July 31, 2030. The award funds research into active genetic systems—CRISPR-based genetic technologies that bypass traditional inheritance patterns to enable self-propagating genetic elements known...
The Salk Institute for Biological Studies received a $515,625 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded May 13, 2026, with a completion date of February 28, 2031. This grant supports fundamental research into the establishment and modulation of deoxyribonucleic acid (DNA) methylation patterns during plant development using Arabidopsis thaliana as a model organism. The research focuses on identifying new factors controlling DNA methylation and understanding how transcription factors, chromatin modifications, and heterochromatin formation regulate methylation patterns, particularly in reproductive tissues where epigenetic patterns influence seed development and intergenerational inheritance. The deliverables from this grant include scientific investigations that will advance understanding of how chemical epigenetic tags control cell differentiation and gene regulation despite identical genetic material across cell types. Research findings are expected to provide insights into both normal developmental processes and the dysregulation of DNA methylation pathways associated with developmental defects in plants and human diseases. The work conducted at the La Jolla, California facility will contribute to the broader biomedical research community's understanding of epigenetic regulation mechanisms and may inform future therapeutic approaches to addressing aberrant methylation-associated pathologies.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 5/15/26 | ||
| Not listed | $515.6k | 5/13/26 |